{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:45:08Z","timestamp":1791225908505,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23\\u202FK06284"],"award-info":[{"award-number":["23\\u202FK06284"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jconrel.2025.113834","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:55:19Z","timestamp":1746795319000},"page":"113834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Intracerebral delivery of the ionic liquid form of edaravone via nose-to-brain delivery route for treating cerebral ischemia\/reperfusion injury"],"prefix":"10.1016","volume":"383","author":[{"given":"Tatsuya","family":"Fukuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotone","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikuto","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Minoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ikeda-Imafuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113834_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jconrel.2025.113834_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/pharmaceutics14020361","article-title":"Application and utility of liposomal neuroprotective agents and biomimetic nanoparticles for the treatment of ischemic stroke","volume":"14","author":"Fukuta","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113834_bb0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113834_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113834_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt233","article-title":"Open questions for Alzheimer\u2019s disease immunotherapy","volume":"6","author":"Golde","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jconrel.2025.113834_bb0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2014possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(01)00532-9","article-title":"Intranasal administration of insulin-like growth factor-I bypasses the blood\u2013brain barrier and protects against focal cerebral ischemic damage","volume":"187","author":"Liu","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jconrel.2025.113834_bb0050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2023.06.005","article-title":"Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys","volume":"359","author":"Sasaki","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2019.03.032","article-title":"Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging","volume":"302","author":"Wingrove","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0060","article-title":"Non-invasive strategies for nose-to-brain drug delivery","volume":"10","author":"Trevino","year":"2020","journal-title":"J. Clin. Trials"},{"key":"10.1016\/j.jconrel.2025.113834_bb0065","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113834_bb0070","doi-asserted-by":"crossref","first-page":"2004819","DOI":"10.1002\/advs.202004819","article-title":"Recent advances in ionic liquids in biomedicine","volume":"8","author":"Curreri","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113834_bb0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2021.08.032","article-title":"Ionic liquids as a useful tool for tailoring active pharmaceutical ingredients","volume":"338","author":"Wu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jconrel.2024.10.034","article-title":"Choline geranate (CAGE): a multifaceted ionic liquid for drug delivery","volume":"376","author":"Mitragotri","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0085","doi-asserted-by":"crossref","first-page":"20191","DOI":"10.1038\/s41598-019-56731-1","article-title":"Transdermal delivery of nobiletin using ionic liquids","volume":"9","author":"Hattori","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113834_bb0090","doi-asserted-by":"crossref","first-page":"eabb6049","DOI":"10.1126\/sciadv.abb6049","article-title":"Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations","volume":"6","author":"Mandal","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.113834_bb0095","doi-asserted-by":"crossref","first-page":"2002912","DOI":"10.1002\/adfm.202002912","article-title":"Ionic liquids and deep eutectic solvents for enhanced delivery of antibodies in the gastrointestinal tract","volume":"31","author":"Angsantikul","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113834_bb0100","doi-asserted-by":"crossref","first-page":"11894","DOI":"10.1021\/acs.chemrev.3c00384","article-title":"Ionic liquids: new forms of active pharmaceutical ingredients with unique, tunable properties","volume":"123","author":"Shamshina","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113834_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molliq.2019.01.063","article-title":"Ionic liquids with methotrexate moieties as a potential anticancer prodrug: synthesis, characterization and solubility evaluation","volume":"278","author":"Moshikur","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2025.113834_bb0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12247-018-9361-x","article-title":"Ionic liquid forms of carvedilol: preparation, characterization, and solubility studies","volume":"14","author":"Shayanfar","year":"2019","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.jconrel.2025.113834_bb0115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/acsmedchemlett.6b00504","article-title":"Transdermal bioavailability in rats of lidocaine in the forms of ionic liquids, salts, and deep eutectic","volume":"8","author":"Berton","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2025.113834_bb0120","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1021\/acs.molpharmaceut.3c00103","article-title":"Development of edaravone ionic liquids and their application for the treatment of cerebral ischemia\/reperfusion injury","volume":"20","author":"Fukuta","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.113834_bb0125","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3390\/ijms25052945","article-title":"Update on antioxidant therapy with Edaravone: expanding applications in neurodegenerative diseases","volume":"25","author":"Yamashita","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.113834_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3164\/jcbn.17-62","article-title":"How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?","volume":"62","author":"Watanabe","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.jconrel.2025.113834_bb0135","first-page":"712","article-title":"Elevated levels of oxidative stress as a prognostic predictor of major adverse cardiovascular events in patients with coronary artery disease","volume":"19","author":"Vassalle","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.jconrel.2025.113834_bb0140","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.3390\/pharmaceutics15112553","article-title":"Utility of a novel Micro-spraying device for intranasal Administration of Drug Solutions to mice","volume":"15","author":"Suzuki","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113834_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2023.06.001","article-title":"Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability","volume":"359","author":"Lu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01959874","article-title":"The plasma volume of the Wistar rat in relation to the body weight","volume":"37","author":"Bijsterbosch","year":"1981","journal-title":"Experientia"},{"key":"10.1016\/j.jconrel.2025.113834_bb0155","doi-asserted-by":"crossref","first-page":"30127","DOI":"10.1038\/srep30127","article-title":"Non-invasive evaluation of neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity","volume":"6","author":"Fukuta","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113834_bb0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijpharm.2016.10.052","article-title":"Development of a novel oral delivery system of edaravone for enhancing bioavailability","volume":"515","author":"Parikh","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113834_bb0165","doi-asserted-by":"crossref","first-page":"2100585","DOI":"10.1002\/adhm.202100585","article-title":"A deep eutectic solvent-based approach to intravenous formulation","volume":"10","author":"Kim","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113834_bb0170","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jconrel.2024.10.038","article-title":"An ionic liquid-based adjuvant for modulating cellular and humoral immune responses","volume":"376","author":"Goetz","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(97)00058-6","article-title":"Anatomy, physiology and function of the nasal cavities in health and disease","volume":"29","author":"Mygind","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113834_bb0180","doi-asserted-by":"crossref","first-page":"33299","DOI":"10.1021\/acsami.3c03900","article-title":"Non-invasive transdermal delivery of antisense oligonucleotides with biocompatible ionic liquids","volume":"15","author":"Toyofuku","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113834_bb0185","doi-asserted-by":"crossref","first-page":"2205389","DOI":"10.1002\/advs.202205389","article-title":"Deep eutectic solvents for subcutaneous delivery of protein therapeutics","volume":"10","author":"Curreri","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113834_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106290","article-title":"Application of ionic liquid to enhance the nose-to-brain delivery of etodolac","volume":"178","author":"Tanigawa","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.113834_bb0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113834_bb0200","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7150\/thno.18219","article-title":"Edaravone-encapsulated agonistic micelles rescue ischemic brain tissue by tuning blood-brain barrier permeability","volume":"7","author":"Jin","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113834_bb0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2005.03.035","article-title":"Free radicals as triggers of brain edema formation after stroke","volume":"39","author":"Heo","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2025.113834_bb0210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/14737175.2023.2251687","article-title":"Oral edaravone\u2013introducing a flexible treatment option for amyotrophic lateral sclerosis","volume":"23","author":"Pattee","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jconrel.2025.113834_bb0215","doi-asserted-by":"crossref","first-page":"16668","DOI":"10.1021\/acsnano.3c02877","article-title":"Encapsulation of an antioxidant in redox-sensitive self-assembled albumin nanoparticles for the treatment of hepatitis","volume":"17","author":"Yasuda","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113834_bb0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-190369","article-title":"Clinical and pathological benefits of edaravone for Alzheimer\u2019s disease with chronic cerebral hypoperfusion in a novel mouse model","volume":"71","author":"Feng","year":"2019","journal-title":"J Alzheimers Disease"},{"key":"10.1016\/j.jconrel.2025.113834_bb0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2008.10.073","article-title":"Edaravone, a free radical scavenger, is effective on neuropathic pain in rats","volume":"1248","author":"Mao","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2025.113834_bb0230","doi-asserted-by":"crossref","first-page":"1601411","DOI":"10.1002\/adhm.201601411","article-title":"Transdermal protein delivery using choline and geranate (CAGE) deep eutectic solvent","volume":"6","author":"Banerjee","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113834_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10191","article-title":"Clinical translation of choline and geranic acid deep eutectic solvent","volume":"6","author":"Ko","year":"2021","journal-title":"Bioeng Transl Med"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:22:48Z","timestamp":1762258968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925004547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"alternative-id":["S0168365925004547"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113834","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebral delivery of the ionic liquid form of edaravone via nose-to-brain delivery route for treating cerebral ischemia\/reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113834"}}